Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > PHIZER just bought Trillium ---for--

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 23, 2021 11:52pm

293 Views

Post# 33753371

RE:RE:RE:PHIZER just bought Trillium ---for--

Trillium partnered with Pfizer last September (2 PH1 drugs) and almost a year later they get bought out. The way it seems to go 1) Good data. 2) partnership with big Pharma which leads up to 3) Buy Out. Just IMHO

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December